Avidity Biosciences (RNA) Net Margin (2019 - 2025)
Historic Net Margin for Avidity Biosciences (RNA) over the last 7 years, with Q3 2025 value amounting to 1395.29%.
- Avidity Biosciences' Net Margin rose 20364800.0% to 1395.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 2628.53%, marking a year-over-year increase of 1384400.0%. This contributed to the annual value of 2955.44% for FY2024, which is 7417800.0% down from last year.
- Per Avidity Biosciences' latest filing, its Net Margin stood at 1395.29% for Q3 2025, which was up 20364800.0% from 4072.37% recorded in Q2 2025.
- Avidity Biosciences' Net Margin's 5-year high stood at 881.69% during Q1 2021, with a 5-year trough of 7332.36% in Q1 2025.
- Moreover, its 5-year median value for Net Margin was 2023.45% (2023), whereas its average is 2470.78%.
- Examining YoY changes over the last 5 years, Avidity Biosciences' Net Margin showed a top increase of 20364800bps in 2025 and a maximum decrease of -53918000bps in 2025.
- Over the past 5 years, Avidity Biosciences' Net Margin (Quarter) stood at 2078.4% in 2021, then increased by 12bps to 1822.07% in 2022, then crashed by -51bps to 2751.39% in 2023, then decreased by -25bps to 3446.28% in 2024, then surged by 60bps to 1395.29% in 2025.
- Its Net Margin stands at 1395.29% for Q3 2025, versus 4072.37% for Q2 2025 and 7332.36% for Q1 2025.